As of Wednesday close, AdaptHealth Corp.’s (NASDAQ:AHCO) stock was up $0.03, moving up 0.25 percent to $12.05. The average number of shares traded per day over the past five days has been 1,273,220 shares. 3 times new highs have been achieved over the past 5 days, with a $0.06 gain in that time frame. In the last twenty days, the average volume was 1,665,770, while in the previous 50 days, it was 1,363,190.
Since last month, AHCO stock retreated -12.43%. Shares of the company fell to $10.86 on 08/17/23, the lowest level in the past month. A 52-week high of $23.30 was reached on 02/23/23 after having rallying from a 52-week low of $9.32. Since the beginning of this year, AHCO’s stock price has dropped by -37.30% or -$7.17, and marked a new high 9 times. However, the stock has declined by -48.28% since its 52-week high.
AHCO stock investors should be aware that AdaptHealth Corp. (AHCO) stock had its last reported insider trading activity 20 days ago on Aug 11. SkyKnight Aero Holdings, LLC, the Director of the company, disposed of 137,787 shares for $14.02 on Aug 11. It resulted in a $1,931,085 divestment by the insider. SkyKnight Aero Holdings, LLC sold 59,052 shares at an average price of $14.02 on Aug 11. The insider now owns 5,565,126 shares following the transaction. On Aug 10, Chief Financial Officer Clemens Jason A bought 720 shares at $14.10 apiece. The transaction was valued at $10,152.
Valuation Metrics
Right now, AdaptHealth Corp. (AHCO) has a P/E ratio of about 41.70. The stock’s beta is 0.71. Besides these, the trailing price-to-sales (P/S) ratio of 0.54, the price-to-book (PB) ratio of 0.74, and the price-to-cash flow ratio of 75.84 may also be considered.
Financial Health
In the three months ended June 29, AdaptHealth Corp.’s quick ratio stood at 1.00, while its current ratio was 1.20, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.98, and the total debt-to-equity ratio was 1.00. On the profitability front, the trailing twelve-month gross margin is 15.20% percent. In the year ended June 29, EBITDA margin amounted to 20.87%, whereas operating margins totaled 4.80%. Based on annual data, AHCO earned $417.43 million in gross profit and brought in $2.97 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 3.60%. Return on equity (ROE) for the past 12 months was 1.80%.
In AdaptHealth Corp.’s quarter-end financial report for June 29, it reported total debt of $2.14 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. AHCO’s revenue rose 8.28% to $744.63 million during the quarter, while net income inched up to $793.29 million. While analysts expected AdaptHealth Corp. to report $0.1 quarterly earnings, the actual figure was $0.09 per share. During the quarter, the company generated $154.87 million in EBITDA. The liabilities of AdaptHealth Corp. were 3.02 billion at the end of its most recent quarter ended June 29, and its total debt was $2.31 billion. The value of shareholders’ equity is $136.11 million.
Technical Picture
This quick technical analysis looks at AdaptHealth Corp.’s (AHCO) price momentum. With a historical volatility rate of 81.12%, the RSI 9-day stood at 42.79% on 30 August.
With respect to its five-day moving average, the current AdaptHealth Corp. price is up by +0.50% percent or $0.06. At present, AHCO shares trade -11.20% below its 20-day simple moving average and -0.82% percent below its 100-day simple moving average. However, the stock is currently trading approximately +16.20% above its SMA50 and -46.70% below its SMA200.
Stochastic coefficient K was 28.60% and Stochastic coefficient D was 22.86%, while ATR was 0.57. Given the Stochastic reading of 37.19% for the 14-day period, the RSI (14) reading has been calculated as 43.35%. As of today, the MACD Oscillator reading stands at 0.18, while the 14-day reading stands at -0.36.
Analyst Ratings
AdaptHealth Corp. downgraded its rating on AdaptHealth Corp. (NASDAQ: AHCO) to a Hold in a note to investors on May 10, 2023. The analysts firm previously had a Buy rating on the stock.AdaptHealth Corp. (AHCO) has been rated Overweight by analysts. According to 0 brokerage firms, AHCO is a sell, and 3 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate AdaptHealth Corp. stock as buy, with 6 recommending it as overweight.
With a median target price of $17.50, the current consensus forecast for the stock is $14.00 – $21.00. Based on these forecasts, analysts predict AdaptHealth Corp. (AHCO) will achieve an average price target of $17.30.
